# contextual query NPC-neuronal-like 4

Query: The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as NPC-neuronal-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['PLP1', 'MBP', 'PTGDS', 'NKAIN2', 'RBFOX1', 'ST18', 'LRRC7', 'KIRREL3', 'SPP1', 'SPOCK3']

The gene list you provided—**PLP1, MBP, PTGDS, NKAIN2, RBFOX1, ST18, LRRC7, KIRREL3, SPP1, and SPOCK3**—shows strong enrichment for molecular features typically associated with oligodendrocyte lineage, neural development, and neuron-glia interactions. This suggests that the **malignant (glioblastoma) cells** in question possess properties and states that overlap with both **neuronal and oligodendrocyte-precursor (OPC) or oligodendrocyte-like cells**, as well as some features that may support tumor growth and altered microenvironmental interactions.

**Key implications from the listed genes:**

- **Myelin and Oligodendrocyte Identity:**  
  - **PLP1** and **MBP** encode major structural proteins of the central nervous system (CNS) myelin sheath, which is produced by oligodendrocytes. Their expression is a hallmark of cells engaged in myelin production and maintenance[1][4][5].
  - The presence of these genes suggests a state of partial or aberrant differentiation toward an oligodendrocyte or OPC phenotype, a finding consistent with some glioblastoma subtypes and certain neural cancers[4].
  - **PTGDS (prostaglandin D2 synthase)** is highly expressed in oligodendrocytes, involved in lipid signaling and may influence myelin stability and CNS immune responses.

- **Neuronal and Synaptic Features:**  
  - **NKAIN2** is implicated in neuronal excitability and potassium ion transport; its expression is prominent in developing neural tissues.
  - **RBFOX1** is a neuronal RNA-binding protein critical for alternative splicing in neurons; it regulates neuronal maturation and synapse function.
  - **LRRC7 (densin-180)** and **KIRREL3** are associated with synaptic structure and function, with LRRC7 being a postsynaptic scaffold protein and KIRREL3 involved in synapse formation and specificity.
  - These features support the notion of "NPC-neuronal-like" identity, suggesting the malignant cells retain or have reactivated developmental gene programs seen in neural precursors and young neurons.

- **Transcriptional and Developmental Regulation:**  
  - **ST18** is a zinc finger transcription factor involved in neural development and has also been linked to tumorigenesis; it can impact apoptosis and differentiation in CNS cells.
  - **RBFOX1** (as above) also participates in neural differentiation.

- **Cell-cell and ECM interactions, Immune Modulation:**  
  - **SPP1 (osteopontin)**: Involved in immune regulation, cell adhesion, migration, and extracellular matrix (ECM) remodeling. In the CNS, it is upregulated in response to injury and can modulate glioma microenvironment, promoting invasion and resistance.
  - **SPOCK3 (testican-3)**: Participates in ECM composition and can regulate cell adhesion, migration, and synaptic plasticity by modulating protease activity and ECM structure.

**Interpretation in the context of cell state, properties, and interactions:**

- **Developmental Plasticity:**  
  The co-expression of oligodendrocyte/myelin genes (PLP1, MBP, PTGDS), neuronal markers (RBFOX1, LRRC7, KIRREL3), and regulators of differentiation (ST18) reflects a hybrid or plastic cell state, reminiscent of neural stem/progenitor cells capable of divergent lineage potential—a common theme in both glioblastoma and neural development[4].
- **Interactions with Neurons and Glia:**  
  The genes suggest these cells might have retained— or reactivated—mechanisms to interact with neurons (through synaptic scaffolds, adhesion molecules, and secreted factors) and respond to, or modify, the surrounding glial and immune landscape (SPP1, PTGDS, SPOCK3).
- **Myelin and Axonal Support:**  
  Expression of myelin genes implies capacity for axon engagement, metabolic support, and modulation of action potential conduction in the CNS, echoing normal oligodendrocyte-axon interactions[1][4].
- **ECM Remodeling/Immune Modulation:**  
  SPP1 and SPOCK3 suggest these cells actively remodel their microenvironment and could both support invasion (through ECM modification) and modulate immune responses (e.g., by recruiting or inhibiting immune cells).
- **Tumor-specific Implications:**  
  Many of these genes (e.g., SPP1, PTGDS, ST18) are implicated in glioma progression, tumor heterogeneity, and the creation of a supportive tumor niche by mimicking developmental and repair programs, which can influence therapy resistance and clinical outcome.

**Summary Table of Selected Gene Functions**

| Gene      | Normal Function                       | Implication in Cancer/Development |
|-----------|--------------------------------------|-----------------------------------|
| PLP1, MBP | Myelin structure, oligodendrocytes   | OPC/oligodendrocyte-like state    |
| PTGDS     | Lipid signaling, myelin/immune       | Tumor microenvironment, immunomodulation |
| RBFOX1    | Neuronal splicing, synaptic maturation | Neuronal features, plasticity     |
| SPP1      | ECM remodeling, immune signaling     | Tumor invasion, immune evasion    |
| SPOCK3    | ECM/protease regulation              | Invasion, synaptic plasticity     |
| KIRREL3, LRRC7 | Synaptic organization         | Neuronal connectivity/migration   |
| ST18      | Transcription factor, differentiation/apoptosis | Tumor progression, response to stress |

**Conclusion**
This gene expression profile defines a malignant cell population with **partial oligodendrocyte differentiation, neuronal-like properties, and altered cell-cell and immune interactions**. Such a state reflects *developmental plasticity* and *microenvironmental adaptability*, typical of aggressive brain tumors, and mirrors programs active during CNS development and repair[4]. This hybrid state may facilitate cell migration, invasion, therapy resistance, and interaction with both neuronal/glial networks and the immune system.



## References

- [1] Identification of potential functional peptides involved in demyelinating injury in the central nervous system https://peerj.com/articles/15846 2023-08-21 None
- [2] Quaking Protein in Myelin Maintenance and Regeneration in the Central Nervous System. https://link.springer.com/10.1007/s12035-025-05144-5 2025-06-24 None
- [3] Complement-membrane regulatory proteins are absent from the nodes of Ranvier in the peripheral nervous system https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-023-02920-9 2023-10-24 None
- [4] DIPG-43. CAN WE REPROGRAM DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)? EXPLORING THE ROLE OF DISTALLESS/DLX HOMEOBOX GENE REGULATION OF OLIGODENDROGLIAL PROGENITOR CELLS (OPC) IN THE DEVELOPING VERTEBRATE NERVOUS SYSTEM https://academic.oup.com/neuro-oncology/article/22/Supplement_3/iii295/6018675 2020-12-01 None
- [5] Myelin acquisition in the central nervous system of the mouse revealed by an MBP-Lac Z transgene https://www.jneurosci.org/lookup/doi/10.1523/JNEUROSCI.12-12-04890.1992 1992-12-01 None